Mariam Elmegaard Malik

461 total citations
25 papers, 275 citations indexed

About

Mariam Elmegaard Malik is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mariam Elmegaard Malik has authored 25 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Cardiology and Cardiovascular Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mariam Elmegaard Malik's work include Diabetes Treatment and Management (13 papers), Heart Failure Treatment and Management (10 papers) and Cardiovascular Function and Risk Factors (5 papers). Mariam Elmegaard Malik is often cited by papers focused on Diabetes Treatment and Management (13 papers), Heart Failure Treatment and Management (10 papers) and Cardiovascular Function and Risk Factors (5 papers). Mariam Elmegaard Malik collaborates with scholars based in Denmark, United States and United Kingdom. Mariam Elmegaard Malik's co-authors include Lars Køber, Emil Loldrup Fosbøl, J. Steen Jensen, Robert W. McCarley, Stuart Winston, Morten Schou, Niels Eske Bruun, Morten Schou, Gunnar Gislason and Christian Torp‐Pedersen and has published in prestigious journals such as Journal of Neuroscience, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Mariam Elmegaard Malik

20 papers receiving 273 citations

Peers

Mariam Elmegaard Malik

EDM

CCM

SURGE

PRM

Masahiko Miyagi Japan

Fredrik von Wowern Sweden

Benjamin Assad Jaghutriz Germany

Mikael Gottsäter Sweden

Hidenori Ishida Japan

Cassandra Fleming United States

Harry Struijker Boudier Netherlands

Mustafa Taskiran Denmark

Giuseppe Bellini Italy

José Manuel Barragán Casas Spain

Masahiko Miyagi Japan

Mariam Elmegaard Malik

244 ×1.4

EDM

75 ×0.9

CCM

100 ×1.8

87 ×1.7

SURGE

25 ×0.6

PRM

Citations per year, relative to Mariam Elmegaard Malik Mariam Elmegaard Malik (= 1×) peers Masahiko Miyagi

Countries citing papers authored by Mariam Elmegaard Malik

Since Specialization

Citations

This map shows the geographic impact of Mariam Elmegaard Malik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariam Elmegaard Malik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariam Elmegaard Malik more than expected).

Fields of papers citing papers by Mariam Elmegaard Malik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariam Elmegaard Malik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariam Elmegaard Malik. The network helps show where Mariam Elmegaard Malik may publish in the future.

Co-authorship network of co-authors of Mariam Elmegaard Malik

This figure shows the co-authorship network connecting the top 25 collaborators of Mariam Elmegaard Malik. A scholar is included among the top collaborators of Mariam Elmegaard Malik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariam Elmegaard Malik. Mariam Elmegaard Malik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Malik, Mariam Elmegaard, Simon Bo Larsen, Caroline Sindet‐Pedersen, et al.. (2025). Temporal trends in the use of oral anticoagulants and clinical outcomes in older, elderly, and very elderly patients with atrial fibrillation: a Danish nationwide study. European Heart Journal.

Malik, Mariam Elmegaard, et al.. (2025). E032 A reminder that a positive PR3-ANCA does not always mean vasculitis. Lara D. Veeken. 64(Supplement_3).

Strange, Jarl Emanuel, Mariam Elmegaard Malik, Gunnar Gislason, et al.. (2024). Temporal Trends in the Initiation of Dialysis Among Patients With Heart Failure With or Without Diabetes: A Nationwide Study From 2002 to 2016. Journal of the American Heart Association. 13(6). e032539–e032539.

Malik, Mariam Elmegaard, Daniel Mølager Christensen, Emil Loldrup Fosbøl, et al.. (2024). Age-specific mortality trends in heart failure over 25 years: a retrospective Danish nationwide cohort study. The Lancet Healthy Longevity. 5(5). e326–e335. 11 indexed citations

Christensen, Daniel Mølager, Christian Torp‐Pedersen, Lars Køber, et al.. (2024). Prognostic Impact of Iron Deficiency in New-Onset Chronic Heart Failure: Danish Heart Failure Registry Insights. ESC Heart Failure. 12(2). 1346–1357. 3 indexed citations

Malik, Mariam Elmegaard, et al.. (2024). Hyponatremia and risk of new-onset heart failure in patients with type 2 diabetes - a real-world study of 70,000 patients. European Heart Journal. 45(Supplement_1).

Videbæk, Lars, Mariam Elmegaard Malik, Jawad H. Butt, et al.. (2024). Excess long-term risk of adverse outcomes in heart failure patients with high and low levels of NT-proBNP: A 7-year follow-up study (NorthStar Trial). IJC Heart & Vasculature. 53. 101441–101441. 1 indexed citations

Strange, Jarl Emanuel, Mariam Elmegaard Malik, Jawad H. Butt, et al.. (2024). Temporal trends in infection-related hospitalizations among patients with heart failure: A Danish nationwide study from 1997 to 2017. American Heart Journal. 278. 83–92. 2 indexed citations

Malik, Mariam Elmegaard, Jawad H. Butt, Jarl Emanuel Strange, et al.. (2023). Initiation of SGLT2 inhibitors and GLP-1 receptor agonists according to level of frailty in people with type 2 diabetes and cardiovascular disease in Denmark: a cross-sectional, nationwide study. The Lancet Healthy Longevity. 4(10). e552–e560. 16 indexed citations

10.

Malik, Mariam Elmegaard, J. Steen Jensen, Charlotte Andersson, et al.. (2023). Discontinuation and reinitiation of SGLT-2 inhibitors and GLP-1R agonists in patients with type 2 diabetes: a nationwide study from 2013 to 2021. The Lancet Regional Health - Europe. 29. 100617–100617. 27 indexed citations

11.

Malik, Mariam Elmegaard & Christopher Holroyd. (2023). An Update on Biosimilars in Rheumatic and Musculoskeletal Disorders. 2(1). 46–46. 1 indexed citations

12.

Strange, Jarl Emanuel, Emil Loldrup Fosbøl, Mariam Elmegaard Malik, et al.. (2023). Initiation of Medical Therapy for Heart Failure Patients According to Kidney Function: A Danish Nationwide Study. Clinical Epidemiology. Volume 15. 855–866.

13.

Holt, Anders, Jarl Emanuel Strange, Mariam Elmegaard Malik, et al.. (2023). Heart Failure Following Anti-Inflammatory Medications in Patients With Type 2 Diabetes Mellitus. Journal of the American College of Cardiology. 81(15). 1459–1470. 9 indexed citations

14.

Andersen, Julie, Mariam Elmegaard Malik, Christian Selmer, et al.. (2022). Impact of socioeconomic position on initiation of SGLT-2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes – a Danish nationwide observational study. The Lancet Regional Health - Europe. 14. 100308–100308. 36 indexed citations

15.

Malik, Mariam Elmegaard, et al.. (2022). Dual biologic therapy for the treatment of rheumatic diseases and asthma: a case series. Rheumatology Advances in Practice. 7(1). rkad018–rkad018. 5 indexed citations

16.

Zareini, Bochra, Paul Blanche, Anders Holt, et al.. (2022). The burden of cardiovascular outcomes in heart failure patients with new-onset, prevalent, and without type 2 diabetes. Clinical Research in Cardiology. 111(4). 460–468. 1 indexed citations

17.

Malik, Mariam Elmegaard, Charlotte Andersson, Paul Blanche, et al.. (2022). Clinical cardiovascular phenotypes and the pattern of future events in patients with type 2 diabetes. Clinical Research in Cardiology. 112(2). 215–226. 1 indexed citations

18.

Malik, Mariam Elmegaard, Christian Madelaire, Maria D’Souza, et al.. (2020). Risk of Heart Failure in Type 2 Diabetes Complicated by Incident Ischaemic Heart Disease and End-Stage Renal Disease. European Journal of Heart Failure. 22(5). 813–820. 4 indexed citations

19.

Jensen, J. Steen, Massar Omar, Caroline Kistorp, et al.. (2020). Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trial. The Lancet Diabetes & Endocrinology. 9(2). 106–116. 84 indexed citations

20.

Malik, Mariam Elmegaard, et al.. (2018). Establishing post mortem criteria for the metabolic syndrome: an autopsy based cross-sectional study. Diabetology & Metabolic Syndrome. 10(1). 36–36. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact